About Biogen Pharmachem Industries Limited
Data last updated: 13 July 2026
Biogen Pharmachem Industries Limited is a public limited company based in Rajkot, Gujarat, India. It specialises in brokerage and trading services, a part of the broader financial services sector. Incorporated on 13 July 1995, the company has been in operation for over 31 years.
Registered with ROC Ahmedabad under CIN L51100GJ1995PLC026702. Listed on BSE: 531752.
Capital: an authorised share capital of ₹108 Cr and a paid-up capital of ₹105.3 Cr. Formerly known as Wellworth Overseas Limited and Sun Techno Overseas Limited. It is led by directors including Chandrakant Govindbhai Parmar and Harshadkumar Chhanabhai Rathod.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Shop No 8 First Floor Makers – 1 Building Jawahar Road, Rajkot, Gujarat, India – 360001.
As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹2.56 Cr, reflecting significant growth compared to the previous year. The net worth stands at ₹99.09 Cr (up 7.79% YoY). Total assets are valued at ₹99.4 Cr (up 8.02% YoY).
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website suntechnooverseas.tk.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Apps
-
Registered AddressShop No 8 First Floor Makers – 1 Building Jawahar Road, Rajkot, Gujarat, India – 360001
-
IndustryFinancial Services, Brokerage & Trading Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Biogen Pharmachem Industries Limited
Biogen Pharmachem Industries Limited has undergone 2 name changes throughout its history. The company was previously known as Wellworth Overseas Limited, and Sun Techno Overseas Limited. The current legal name is Biogen Pharmachem Industries Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Biogen Pharmachem Industries Limited | Current |
| Wellworth Overseas Limited | Previous |
| Sun Techno Overseas Limited | Previous |
CIN History of Biogen Pharmachem Industries Limited
Biogen Pharmachem Industries Limited has one previous CIN (Corporate Identification Number): L65910GJ1995PLC026702. The current CIN is L51100GJ1995PLC026702, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L51100GJ1995PLC026702 | Current |
| L65910GJ1995PLC026702 | Previous |
Auditor Details of Biogen Pharmachem Industries Limited
Biogen Pharmachem Industries Limited is audited by Goenka Mehta & Associates Chartered Accountants (ICAI peer reviewed, certificate valid till 2027-11-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Goenka Mehta & Associates Chartered Accountants (ICAI peer reviewed, certificate valid till 2027-11-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Biogen Pharmachem Industries Limited
Biogen Pharmachem Industries Limited is currently managed by 6 directors, with 31 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrakant Govindbhai Parmar | Director | 22 Nov 2021 | 4 Years 7 Months | Current |
| Harshadkumar Chhanabhai Rathod | Director | 22 Mar 2023 | 3 Years 3 Months | Current |
| Narendrakumar Ashokbhai Vaniya | Director | 22 Mar 2023 | 3 Years 3 Months | Current |
| Aman Pravinkumar Patel | Director | 05 Feb 2025 | 1 Years 5 Months | Current |
| Kelash Bunkar | Whole-Time Director | 05 Feb 2025 | 1 Years 5 Months | Current |
| Chhayaben Maheshbhai Parmar | Director | 09 Jan 2024 | 2 Years 6 Months | Current |
Financials of Biogen Pharmachem Industries Limited FY 2026 filings available
Biogen Pharmachem Industries Limited reported revenue of ₹2.56 Cr (up 205.1% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹2.56 Cr | ₹83.84 Lakh | ₹0 | ₹82.83 Lakh | ₹2.16 Cr | ₹1.62 Cr | ₹0 | ₹94.99 Lakh |
| Other Income | ₹0 | ₹0 | ₹2.38 Cr | ₹0 | ₹68,000 | -₹1.61 Cr | ₹0 | ₹0 |
| Total Income | ₹2.56 Cr | ₹83.84 Lakh | ₹2.38 Cr | ₹82.83 Lakh | ₹2.17 Cr | ₹1.45 Lakh | ₹0 | ₹94.99 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹2.01 Cr | ₹1.48 Cr | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹89 Lakh |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹28.28 Lakh | ₹16.79 Lakh | ₹8.4 Lakh | ₹17.45 Lakh | ₹5.42 Lakh | ₹1.39 Lakh | ₹3.6 Lakh | ₹3.68 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Expenses | ₹1.32 Cr | ₹96.32 Lakh | ₹36.68 Lakh | ₹19.83 Lakh | ₹10.83 Lakh | ₹12.32 Lakh | ₹8.07 Lakh | ₹66,000 |
| Total Expenses | ₹1.6 Cr | ₹1.13 Cr | ₹45.08 Lakh | ₹37.28 Lakh | ₹2.18 Cr | ₹1.62 Cr | ₹11.67 Lakh | ₹93.34 Lakh |
| Profit Before Exceptional Items & Tax | ₹95.67 Lakh | -₹29.27 Lakh | ₹1.93 Cr | ₹45.55 Lakh | -₹86,000 | -₹1.6 Cr | -₹11.67 Lakh | ₹1.65 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹95.67 Lakh | -₹29.27 Lakh | ₹1.93 Cr | ₹45.55 Lakh | -₹86,000 | -₹1.6 Cr | -₹11.67 Lakh | ₹1.65 Lakh |
| Total Tax Expense | ₹9.73 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Profit | ₹85.94 Lakh | -₹29.27 Lakh | ₹1.93 Cr | ₹45.55 Lakh | -₹86,000 | -₹1.6 Cr | -₹11.67 Lakh | ₹1.65 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹85.94 Lakh | -₹29.27 Lakh | ₹1.93 Cr | ₹45.55 Lakh | -₹86,000 | -₹1.6 Cr | -₹11.67 Lakh | ₹1.65 Lakh |
| EBITDA (computed) | ₹95.67 Lakh | -₹29.27 Lakh | ₹1.93 Cr | ₹45.55 Lakh | -₹86,000 | -₹1.6 Cr | -₹11.67 Lakh | ₹1.65 Lakh |
| Basic EPS | ₹0.01 | ₹0.00 | ₹0.00 | ₹0.01 | ₹0.00 | ₹-0.02 | ₹0.00 | ₹-1.01 |
| Diluted EPS | ₹0.01 | ₹0.00 | ₹0.00 | ₹0.01 | ₹0.00 | ₹-0.02 | ₹0.00 | ₹-1.01 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹99.4 Cr | ₹92.02 Cr | ₹56.82 Cr | ₹54.74 Cr | ₹54.95 Cr | ₹54.19 Cr | ₹56.09 Cr | ₹57.63 Cr |
| Non-current Assets | ₹98.91 Cr | ₹89.36 Cr | ₹56.75 Cr | ₹54.6 Cr | ₹53.02 Cr | ₹51.69 Cr | ₹48.05 Cr | ₹45.22 Cr |
| Current Assets | ₹48.69 Lakh | ₹2.66 Cr | ₹7.05 Lakh | ₹14.5 Lakh | ₹1.93 Cr | ₹2.5 Cr | ₹8.04 Cr | ₹12.41 Cr |
| Property, Plant & Equipment | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Trade Receivables | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹2.48 Cr | ₹8.03 Cr | ₹7.03 Cr |
| Cash & Equivalents | ₹32.16 Lakh | ₹5.48 Lakh | ₹63,000 | ₹87,000 | ₹20,000 | ₹75,000 | ₹34,000 | ₹31,000 |
| Equity (Net Worth) | ₹99.09 Cr | ₹91.93 Cr | ₹56.52 Cr | ₹54.59 Cr | ₹54.13 Cr | ₹54.14 Cr | ₹55.75 Cr | ₹54.29 Cr |
| Equity Share Capital | ₹90.26 Cr | ₹65.26 Cr | ₹65.26 Cr | ₹65.26 Cr | ₹65.26 Cr | ₹65.26 Cr | ₹65.26 Cr | ₹65.26 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹30.59 Lakh | ₹63.02 Lakh |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹81.54 Lakh | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹0 | ₹81.54 Lakh | ₹0 | ₹30.59 Lakh | ₹63.02 Lakh |
| Current Liabilities | ₹21.45 Lakh | ₹9 Lakh | ₹30.19 Lakh | ₹15.36 Lakh | ₹81.54 Lakh | ₹4.74 Lakh | ₹4.05 Lakh | ₹1.12 Cr |
| Total Liabilities | ₹31.18 Lakh | ₹9 Lakh | ₹30.19 Lakh | ₹15.36 Lakh | ₹81.54 Lakh | ₹4.74 Lakh | ₹34.64 Lakh | ₹3.34 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹1.57 Cr | -₹1.09 Cr | ₹1.97 Cr | ₹1.63 Cr | ₹1.4 Cr |
| Investing Cash Flow | -₹9.56 Cr | -₹32.61 Cr | -₹2.08 Cr | -₹1.58 Cr | -₹1.32 Cr |
| Financing Cash Flow | ₹6.3 Cr | ₹35.7 Cr | ₹0 | ₹0 | ₹0 |
| Capital Expenditure | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Free Cash Flow (computed) | ₹1.57 Cr | -₹1.09 Cr | ₹1.97 Cr | ₹1.63 Cr | ₹1.4 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹1.69 Cr | ₹2 Cr | -₹11.17 Lakh | ₹4.56 Lakh | ₹7.56 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹57.82 Lakh | ₹0 | ₹0 | ₹1.54 Cr | ₹1.35 Cr | ₹0 | ₹0 | -₹9.09 Lakh |
| Other Income | ₹0 | ₹54.19 Lakh | -₹10.49 Lakh | ₹0 | ₹0 | ₹22.76 Lakh | -₹65.05 Lakh | ₹0 |
| Total Income | ₹57.82 Lakh | ₹54.19 Lakh | -₹10.49 Lakh | ₹1.54 Cr | ₹1.35 Cr | ₹22.76 Lakh | -₹65.05 Lakh | -₹9.09 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹10.31 Lakh | ₹6.51 Lakh | ₹5.13 Lakh | ₹6.33 Lakh | ₹9.33 Lakh | ₹5.05 Lakh | ₹1.03 Lakh | ₹1.38 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Expenses | ₹83.39 Lakh | ₹1.45 Lakh | ₹33.54 Lakh | ₹13.47 Lakh | ₹8.12 Lakh | ₹49.2 Lakh | ₹33.65 Lakh | ₹5.35 Lakh |
| Total Expenses | ₹93.7 Lakh | ₹7.96 Lakh | ₹38.67 Lakh | ₹19.8 Lakh | ₹17.45 Lakh | ₹54.25 Lakh | ₹34.68 Lakh | ₹6.73 Lakh |
| Profit Before Exceptional Items & Tax | -₹35.88 Lakh | ₹46.23 Lakh | -₹49.16 Lakh | ₹1.34 Cr | ₹1.18 Cr | -₹31.49 Lakh | -₹99.73 Lakh | -₹15.82 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹35.88 Lakh | ₹46.23 Lakh | -₹49.16 Lakh | ₹1.34 Cr | ₹1.18 Cr | -₹31.49 Lakh | -₹99.73 Lakh | -₹15.82 Lakh |
| Total Tax Expense | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹35.88 Lakh | ₹46.23 Lakh | -₹49.16 Lakh | ₹1.34 Cr | ₹1.18 Cr | -₹31.49 Lakh | -₹99.73 Lakh | -₹15.82 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹35.88 Lakh | ₹46.23 Lakh | -₹49.16 Lakh | ₹1.34 Cr | ₹1.18 Cr | -₹31.49 Lakh | -₹99.73 Lakh | -₹15.82 Lakh |
| EBITDA (computed) | -₹35.88 Lakh | ₹46.23 Lakh | -₹49.16 Lakh | ₹1.34 Cr | ₹1.18 Cr | -₹31.49 Lakh | -₹99.73 Lakh | -₹15.82 Lakh |
| Basic EPS | ₹0.00 | ₹0.01 | ₹-0.01 | ₹0.01 | ₹0.02 | ₹0.00 | ₹-0.02 | ₹0.00 |
| Diluted EPS | ₹0.00 | ₹0.01 | ₹-0.01 | ₹0.01 | ₹0.02 | ₹0.00 | ₹-0.02 | ₹0.00 |
Shareholding Pattern of Biogen Pharmachem Industries Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, domestic institutional investors hold 0.00%, retail and other public shareholders hold 100.00% of Biogen Pharmachem Industries Limited. The company had 289,155 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | - | - | - | - | - | - |
| Public | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | - | - | - |
| Public | 100.00% | 100.00% | 100.00% |
| Promoter change (YoY, %pts) | - | - | - |
Charges & Borrowings Biogen Pharmachem Industries Limited
Biogen Pharmachem Industries Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Biogen Pharmachem Industries Limited
View historical data on people associated with Biogen Pharmachem Industries Limited, including employment history and EPFO contributions.
Employee and EPFO history for Biogen Pharmachem Industries Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Biogen Pharmachem Industries Limited
GST registrations and filing compliance for Biogen Pharmachem Industries Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Biogen Pharmachem Industries Limited
Credit ratings, litigation, and regulatory alerts for Biogen Pharmachem Industries Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Biogen Pharmachem Industries Limited
MSME payment history for Biogen Pharmachem Industries Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Biogen Pharmachem Industries Limited
Corporate group structure for Biogen Pharmachem Industries Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Biogen Pharmachem Industries Limited
MCA filings and documents for Biogen Pharmachem Industries Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Biogen Pharmachem Industries Limited
Frequently Asked Questions about Biogen Pharmachem Industries Limited
Biogen Pharmachem Industries Limited is an active public limited company in the financial services sector based in Rajkot, Gujarat, India. It was incorporated on 13 July 1995 (31+ years old) and is registered under CIN L51100GJ1995PLC026702. Listed on BSE: 531752.
Biogen Pharmachem Industries Limited reported revenue of ₹2.56 Cr for FY 2026 (up 205.1% YoY) based on standalone BSE filings.
The current directors of Biogen Pharmachem Industries Limited are:
- Chandrakant Govindbhai Parmar - Director
- Harshadkumar Chhanabhai Rathod - Director
- Narendrakumar Ashokbhai Vaniya - Director
- Aman Pravinkumar Patel - Director
- Kelash Bunkar - Whole-Time Director
- Chhayaben Maheshbhai Parmar - Director
The primary industry of Biogen Pharmachem Industries Limited is financial services. The company specifically operates in brokerage and trading services. The company is currently active in this sector.
Yes. Biogen Pharmachem Industries Limited is listed on BSE with code 531752.
Biogen Pharmachem Industries Limited can be reached at the registered office: Shop No 8 First Floor Makers – 1 Building Jawahar Road, Rajkot, Gujarat, India – 360001, or through the website suntechnooverseas.tk.